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Introduction and Purpose
Neonatal Abstinence Syndrome (NAS) is a
growing worldwide pandemic and is a
threat to the health of diagnosed infants
(Alemu et al., 2020). Symptoms of NAS
include low-birth weights, difficulty
feeding, unsoothable irritability, and
seizures (Barfield et al., 2017). Evidence
has shown that these impacts extend into
childhood, negatively affecting growth and
development (Fill et al., 2018). The purpose
of this study is to analyze the impact of
NAS on infants, their mothers, and the
nurses who care for the infants. We also
identify several effective pharmacological
and nonpharmacological interventions to
counteract NAS withdrawal symptoms.

Background and Significance
NAS is a substance-withdrawal disorder that
impacts infants that have been exposed to
addictive substances in utero; substances include
methadone, buprenorphine, narcotics, opioids,
alcohol, illegal substances, and more. NAS
presents as respiratory distress, low birth weight,
poor feeding, and irritability soon after birth
(Alemu et al., 2019).
NAS across the US has increased by threefold
since the 2000s; however, Tennessee has
increased by tenfold (Tennessee Department of
Health).
More than 5% of women use illicit drugs during
pregnancy and 49-94% of infants who are
exposed to illicit drugs or opioids experience
NAS (Johnson, 2017). Additionally, children
born with NAS are 3.2 times more likely to have
a greater number of healthcare insurance claims
through age 8; these claims are also more costly
(Guodong et al., 2019).
In 2016, an estimated $1.8 billion in medical
expenses from neonatal hospitalizations resulted
from NAS (Alemu et al., 2019).
Lawmakers across the United States feel that
opioid abuse during pregnancy is the main
concern; however, research supports any
substance that is abused during pregnancy is
harmful to a fetus and can cause an infant
experience NAS upon birth (Woodruf & Roberts,
2019).
In a study by Rockefeller et al. (2019), they
analyzed the mother’s perspective. The study
focused on their experiences with healthcare
workers, support groups, and the obstacles they
faced when bonding and caring for their child.

(Winkelman et. al., 2018).

Key Findings
A study by Parlaman (2019) found that by
introducing nonpharmacological treatments, the
infant with NAS hospital stay reduced from nine
days to six days as well as a 60% decrease in
morphine use. Morphine use dropped from 63%
to 23%.
Such non-pharmacological treatments include
in-rooming with the mother, limiting light/sound
exposure, and not using the Finnegan tool for
assessing NAS because this contradicts idea of
limited stimuli (Loyal et al., 2019).
NAS is a growing pandemic, specifically in rural
areas with high poverty rates. An example would
be the Appalachian area of East Tennessee. This
region experiences NAS at a rate of 28.5 per
1,000 live births compared to the state of
Tennessee’s rate of 12.7 per 1,000 live births
(Erwin, 2017).
In the Rockefeller et al. study (2019) the women
interviewed reported overwhelming support from
healthcare professionals; however, there was a
lack of information about NAS from them.
Instead, the mothers gathered information from
other mothers and support groups for NAS.
Another study on the mother’s perspective
reported they often felt criticized or judged by
healthcare workers, making it more difficult for
them to seek help when they know that they have
a substance abuse issue (Johnson, 2017).
In an focused ethnography by Nelson (2016),
NICU nurses expressed grief, exhaustion, and
frustration when caring for neonates affected by
maternal substance abuse in utero (pp. 34-74).
Nurses also reported difficulty during
interactions with mothers because they were
often anxious and have complex psychosocial
issues (Loyal et al., 2019).

Conclusion
The NAS pandemic stems from the growing
opioid crisis. Proper prescription of controlled
substances, accurate surveillance of the trends of
NAS, and available treatments for expecting
mothers are ways the Center for Disease Control
and Prevention (CDC) is tackling the crisis
(Barfield et al., 2017). Standardization of
assessing infants at risk for NAS is needed to
provide quality care to these infants.
Non-pharmacological methods, such as
in-rooming, low stimulus environments, and
breastfeeding, should be pursued before narcotic
treatment (Barfield et al., 2017; Loyal et al.,
2019).
Methods of preventing NAS include educating
the general public about NAS, especially
pregnant woman who may battle substance
abuse. Many physicians recommend prescribing
non opioid methods of treatment for pain (Ko et.
al, 2017). State lawmakers should also stay
abreast of the current conditions of NAS in their
states and work to decriminalize the situation so
women can seek prenatal care without fear of
being charged.
Posters/pamphlets, speaking at SUD meetings,
and educating mothers about NAS are ways to
inform the general public about this growing
crisis.

Literature Review and Methods
The Literature Review for Neonatal Abstinence
Syndrome (NAS) analyzed 20 articles on the
topic of NAS and the effects on mothers, infants,
and nurses.
Pubmed and CINAHL were used to collect
articles written within the past five years.
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